Peddock Capital Advisors, LLC Merck & Co., Inc. Transaction History

Peddock Capital Advisors, LLC

$392 Million
Q1 2025

A detailed history of Peddock Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Peddock Capital Advisors, LLC holds 10,145 shares of MRK stock, worth $815,962. This represents 0.23% of its overall portfolio holdings.

Number of Shares

10,145

Previous 11,459 11.47%

Holding current value

$815,962

Previous $1.14 Million 20.11%

% of portfolio

0.23%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$83.01 - $101.02 $109,075 - $132,740	-1,314 Reduced 11.47%	10,145 $910,000
Q4 2024 Jan 13, 2025	SELL	$96.31 - $114.76 $596,158 - $710,364	-6,190 Reduced 35.07%	11,459 $1.14 Million
Q3 2024 Oct 08, 2024	BUY	$111.15 - $128.97 $31,900 - $37,014	287 Added 1.65%	17,649 $2 Million
Q2 2024 Jul 18, 2024	BUY	$123.8 - $132.96 $22,036 - $23,666	178 Added 1.04%	17,362 $2.15 Million
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $87,874 - $102,393	776 Added 4.73%	17,184 $2.27 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $71,628 - $77,949	-715 Reduced 4.18%	16,408 $1.79 Million
Q3 2023 Oct 10, 2023	BUY	$102.95 - $114.33 $33,870 - $37,614	329 Added 1.96%	17,123 $1.76 Million
Q2 2023 Aug 07, 2023	BUY	$108.61 - $118.38 $139,672 - $152,236	1,286 Added 8.29%	16,794 $1.94 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $80,602 - $89,935	783 Added 5.32%	15,508 $1.65 Million
Q4 2022 Feb 02, 2023	BUY	$87.44 - $112.11 $75,985 - $97,423	869 Added 6.27%	14,725 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $113,946 - $128,006	1,348 Added 10.78%	13,856 $1.19 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $16,614 - $18,833	199 Added 1.62%	12,508 $1.14 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $575,068 - $644,615	7,823 Added 174.39%	12,309 $1.01 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $10,986 - $13,762	152 Added 3.51%	4,486 $344,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $279,623 - $307,515	-3,901 Reduced 47.37%	4,334 $326,000
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $14,765 - $16,331	210 Added 2.62%	8,235 $633,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $59,150 - $69,673	859 Added 11.99%	8,025 $619,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $74,856 - $83,074	1,043 Added 17.03%	7,166 $586,000
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $57,007 - $64,618	779 Added 14.58%	6,123 $508,000
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $176,472 - $200,805	2,506 Added 88.3%	5,344 $413,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $28,765 - $39,870	454 Added 19.04%	2,838 $218,000
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $139,869 - $150,501	2,384	2,384 $153,000

Others Institutions Holding MRK

# of Institutions

3,889

Shares Held

1.93B

Call Options Held

21M

Put Options Held

18.9M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $204B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peddock Capital Advisors, LLC with notifications on news.

Account

Peddock Capital Advisors, LLC Merck & Co., Inc. Transaction History